Results 211 to 220 of about 253,180 (311)
Towards better understanding of factors contributing to medical physicist well-being in academic medical centers: A systems-analysis approach. [PDF]
Kwong E +13 more
europepmc +1 more source
Hospital Culture and Intensity of End-of-Life Care at 3 Academic Medical Centers.
Dzeng E +5 more
europepmc +1 more source
Objective Despite guideline recommendations, long‐term glucocorticoid (GC) use is common in rheumatoid arthritis (RA). We conducted a clinician survey nested within a large registry to identify patient and clinician factors associated with GC use. Methods Clinicians contributing patients to the CorEvitas Rheumatoid Arthritis Registry were surveyed ...
Michael D. George +7 more
wiley +1 more source
Industry Support of Researchers in Universities and Academic Medical Centers [PDF]
Gorski, Andrzej
core
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko +4 more
wiley +1 more source
Language Availability of Patient Portals at Academic Medical Centers in the United States. [PDF]
Prada-Rey N, Samal L, Rodriguez JA.
europepmc +1 more source
Interstitial lung disease (IRD‐ILD) is a significant cause of morbidity and mortality in patients with inflammatory rheumatic disorders (IRD). High‐resolution computed tomography (HRCT) is widely considered the gold standard for the non‐invasive assessment of ILD; however, its interpretation is constrained by substantial inter‐observer variability and ...
Alexander Pfeil +7 more
wiley +1 more source
Diagnostic CT Scans: Institutional Informed Consent Guidelines and Practices at Academic Medical Centers [PDF]
Lee, Christopher I. +4 more
core +1 more source
Facial cosmetic therapy use amongst patients with systemic sclerosis: an Australian cohort study
Objective Systemic sclerosis (SSc) is associated with numerous facial manifestations for which patients may engage in cosmetic therapies. It is unclear how patients with SSc use these therapies. This study sought to characterise patient engagement and experiences with cosmetic therapies for SSc‐related and non‐SSc‐related facial changes.
Zachary Warren +11 more
wiley +1 more source

